The meeting provided an important opportunity for international dialogue and discussion of current clinical practices, as well as for sharing experiences regarding opportunities for further development and improvement of healthcare. Participants included experts from Bosnia and Herzegovina, the Russian Federation, Serbia, Croatia, Libya, Georgia, Kosovo, Ukraine, Moldova, Albania, Türkiye, North Macedonia and Montenegro.
The programme featured a series of expert presentations and discussions, during which various professional and clinical experiences in the treatment of upper respiratory tract diseases in the fields of infectious diseases, paediatrics and otorhinolaryngology were presented. Particular attention was paid to the importance of modern therapeutic approaches, the exchange of scientific knowledge, and fostering connections among experts from different healthcare systems.
The meeting also addressed the significance of Lysobact on the pharmaceutical market. Years of experience and trust are an important part of the product's recognition among generations of healthcare professionals and patients.
Professor Aleksandr Vasilievich Gorelov, Academician of the Russian Academy of Sciences and Deputy Director for Science at the Central Research Institute of Epidemiology in Moscow, also spoke about the importance of the product's longstanding presence on the market, stating:
"Lysobact is the gold standard among topical antiseptics. Its longstanding presence on the pharmaceutical market is a testament to its high efficacy and proven safety profile, established over time and confirmed through clinical practice.”
Professor Elena Petrovna Karpova, a paediatrician and paediatric otorhinolaryngologist from Moscow, spoke about the trust in Lysobact shared across generations:
"Lysobact represents a bond between generations. Our grandmothers used it to relieve throat discomfort, and today we entrust it with what is most precious to us – the health of our children.”
One of the key programme highlights was the presentation of the publication Lysobact Medical Evidence Book of Abstracts, which contributes to the documentation of medical evidence regarding the efficacy and safety of medicines and other preparations containing lysozyme.
The meeting also highlighted the role of lysozyme in addressing the global problem of bacterial resistance to antibiotics.
By organising this international meeting, Bosnalijek continues to develop cooperation with medical experts and the scientific community, creating opportunities for open dialogue, the exchange of experience and networking among experts from different countries.
Such gatherings contribute to a better
understanding of current medical needs and expectations and represent an
important part of the company's ongoing commitment to improving the quality of
healthcare.